Search
for
Sort by
Research 271–300 of 1000+
- Ovarian and Adrenal Androgens and Their Link to High Human Chorionic Gonadotropin Levels: A Prospective Controlled Study
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Postmenopausal Alopecia due to Ovarian Hyperandrogenemia Treated with Bilateral Salpingo-oophorectomy
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Rational investigations in the diagnosis and management of women with hirsutism or androgenetic alopecia
- Disorders of ovulation
- Understanding polycystic ovary syndrome
- Impact of Testosterone on Hair and Skin
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Cardiac flow parameters with conventional and pulsed tissue Doppler echocardiography imaging in patients with polycystic ovary syndrome
- A review on PCOS: Its causes, symptoms, pathogenesis and management
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Secondary amenorrhea
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Androgen excess: a hallmark of polycystic ovary syndrome
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Androgen excess is the key element in polycystic ovary syndrome
- Hormonal Therapy for Acne
- Hormonal contraceptives: pharmacology tailored to women's health
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Pharmacotherapy of polycystic ovary syndrome - an update
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications